Clinical Trial Detail

NCT ID NCT02022982
Title PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

Palbociclib + PD-0325901

Age Groups: adult senior

Additional content available in CKB BOOST